336 related articles for article (PubMed ID: 26961346)
1. The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.
Hu SL; Chang A; Perazella MA; Okusa MD; Jaimes EA; Weiss RH;
J Am Soc Nephrol; 2016 Aug; 27(8):2227-37. PubMed ID: 26961346
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics and Metabolic Reprogramming in Kidney Cancer.
Weiss RH
Semin Nephrol; 2018 Mar; 38(2):175-182. PubMed ID: 29602399
[TBL] [Abstract][Full Text] [Related]
3. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
[TBL] [Abstract][Full Text] [Related]
5. VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment.
Rathmell WK; Chen S
Expert Rev Anticancer Ther; 2008 Jan; 8(1):63-73. PubMed ID: 18095884
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of renal cell cancer and the identification of therapeutic targets.
Iliopoulos O
J Clin Oncol; 2006 Dec; 24(35):5593-600. PubMed ID: 17158545
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective.
Li ZC; Zhai G; Zhang J; Wang Z; Liu G; Wu GY; Liang D; Zheng H
Eur Radiol; 2019 Aug; 29(8):3996-4007. PubMed ID: 30523454
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Management of Hereditary Renal Cell Cancer.
Menko FH; Maher ER
Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma for the nephrologist.
Perazella MA; Dreicer R; Rosner MH
Kidney Int; 2018 Sep; 94(3):471-483. PubMed ID: 29661544
[TBL] [Abstract][Full Text] [Related]
12. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.
Mehdi A; Riazalhosseini Y
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28812986
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
14. [Molecular biology of the clear cell renal cell carcinoma: principles for a selective treatment].
Grande Pulido E; Martín Centeno A; Maroto Rey P; Solsona Narbón E
Actas Urol Esp; 2007 Mar; 31(3):233-43. PubMed ID: 17658151
[TBL] [Abstract][Full Text] [Related]
15. The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy.
Lai Y; Tang F; Huang Y; He C; Chen C; Zhao J; Wu W; He Z
J Cell Physiol; 2021 Mar; 236(3):1616-1627. PubMed ID: 32783202
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study.
Hughson MD; Schmidt L; Zbar B; Daugherty S; Meloni AM; Silva FG; Sandberg AA
J Am Soc Nephrol; 1996 Nov; 7(11):2461-8. PubMed ID: 8959640
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma: basic biology and clinical behavior.
Franklin JR; Figlin R; Belldegrun A
Semin Urol Oncol; 1996 Nov; 14(4):208-15. PubMed ID: 8946619
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma: current status and emerging therapies.
Nelson EC; Evans CP; Lara PN
Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
[TBL] [Abstract][Full Text] [Related]
19. Hereditary Renal Cell Carcinoma Syndromes.
Carlo MI
Hematol Oncol Clin North Am; 2023 Oct; 37(5):841-848. PubMed ID: 37258351
[TBL] [Abstract][Full Text] [Related]
20. Renal Cell Carcinoma Presenting as Carcinoma of Unknown Primary Site: Recognition of a Treatable Patient Subset.
Greco FA; Hainsworth JD
Clin Genitourin Cancer; 2018 Aug; 16(4):e893-e898. PubMed ID: 29610002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
